Five details:
1. Three private equity firms, Blackstone, Carlyle and Hellman & Friedman, partnered with Singapore’s sovereign wealth fund GIC for a majority investment in Medline, the companies announced June 5.
2. The transaction, valued at more than $30 billion according to The Wall Street Journal, is expected to close in late 2021.
3. In 2020, Medline reported $17.5 billion in revenue and the company plans to use the new funds to expand product offerings, grow faster internationally and invest in global supply chain infrastructure.
4. Post-transaction, the Mills family will still be the largest single shareholder and Medline will remain a privately held, family-led company. The senior management team is staying entact.
5. This investment in Medline is the largest leveraged buyout in more than 10 years, according to the Journal.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
